Industry Reports

Certara announced that it has acquired BaseCase Management GmbH, a data visualization software as a service (SaaS) company headquartered in Berlin, Germany, with offices in New York.…
Read More...

Selvita S.A. (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for oncology patients and drug discovery services, announced the…
Read More...

Roivant Sciences and ArQule announced the initiation of a collaboration to pursue the development of derazantinib, a pan-FGFR (fibroblast growth factor receptor) inhibitor, in Greater…
Read More...

NetVation DL Medicine announced that it has entered into a two-year research collaboration with Pfizer Inc (NYSE: PFE). Under the terms of the agreement, DL Medicine will screen and…
Read More...

Liquidia Technologies announced the appointment of Kevin Gordon as President and Chief Financial Officer. Mr. Gordon will oversee finance operations and strategy, corporate development…
Read More...

Allergan plc announced that Matthew M. Walsh has been appointed Executive Vice President and Chief Financial Officer. He will formally join Allergan later this month following a…
Read More...

International contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, Cobra Biologics and Symbiosis Pharmaceutical Services asserted having clinched…
Read More...

Anika Therapeutics integrated orthopedic medicines company based on its proprietary hyaluronic acid ("HA") technology, today announced an agreement with the Institute of Integrative…
Read More...

Biopharmaceutical company focused on developing Western drug candidates in China and North Asia, CANbridge Life Sciences undertakes licensing agreement to develop and commercialize…
Read More...

As U.S is facing the wrath of flu that has become widespread in U.S, FDA continues to oversee this situation closely. FDA Commissioner, Scott Gottlieb vows to take steps to curb saline…
Read More...

The coalition, known as the National Conference of Pharmaceutical Organizations (NCPO), and American Pharmacists Association (APhA) issued a public statement seeking support from the…
Read More...

Select Medical Holdings Corporation and Dignity Health asserted the completion of the transaction to combine Concentra Group with U.S HealthWorks, Inc, a subsidiary of Dignity Health …
Read More...

Clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, Syndax Pharmaceuticals ventured into new Clinical collaboration with AstraZeneca to…
Read More...

Ambry Genetics and Invicro partner to offer customized genomics and imaging services for the pharmaceutical and biotechnology industry, exhibiting profound emphasis on Oncology and…
Read More...

In a strategic merger revelation, Seattle Genetics and Cascadian Therapeutics signed a definitive merger agreement under which Seattle Genetics has conceded to acquire Cascadian…
Read More...

Hisamitsu Pharmaceutical in collaboration with U.S subsidiary, Novel Pharmaceuticals, Inc declares that the the transdermal patch for the treatment of schizophrenia Development code:…
Read More...

QIAGEN N.V forays into an agreement to acquire STAT-Dx to develop the next generation of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes…
Read More...

Authentidate Holding Corp asserted completion of its Corporate name change to Aeon Global Health Corp with  effect immediately. The name change is part of the company's broader…
Read More...

SkylineDX affirmed foraying into a strategic collaboration to curate novel diagnostic tests to enhance clinical decision making for melanoma patients. The Joint development agreement…
Read More...

CorePharma acquired by Investor Group, its facilities and equipment in Middlesex, NJ from Impax Laboratories. Financial terms of the acquisition were not disclosed. The acquisition does…
Read More...